These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10880677)

  • 21. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
    J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway.
    Weick BG; Walters JR
    Neuropharmacology; 1987 Jun; 26(6):641-4. PubMed ID: 2955245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 2. 2-deoxy-D-glucose.
    Schaefer LA; Koch JE; Bodnar RJ
    Pharmacol Biochem Behav; 1994 Sep; 49(1):205-11. PubMed ID: 7816875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model.
    Rehders JH; Löscher W; Richter A
    Neuroscience; 2000; 97(2):267-77. PubMed ID: 10799758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
    Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
    Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.
    Nowak P; Dabrowska J; Bortel A; Biedka I; Szczerbak G; Słomian G; Kostrzewa RM; Brus R
    Eur J Pharmacol; 2006 Dec; 552(1-3):46-54. PubMed ID: 17055481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.
    Dunnett SB; Björklund A; Stenevi U; Iversen SD
    Brain Res; 1981 Dec; 229(2):457-70. PubMed ID: 6796197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine mediated responses in 6-hydroxydopamine lesioned rats involve changes of the signal transduction.
    Barone P; Popoli M; Morelli M; Cicarelli G; Campanella G; Di Chiara G
    J Neural Transm Suppl; 1995; 45():83-90. PubMed ID: 8748613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior.
    Yurek DM; Hipkens SB
    Brain Res; 1993 Sep; 623(1):56-64. PubMed ID: 8221093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
    Popoli P; Pèzzola A; Torvinen M; Reggio R; Pintor A; Scarchilli L; Fuxe K; Ferré S
    Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.